Streetbeat News

Stock Prices

PODD

Analysts have provided various ratings for Insulet (NASDAQ:PODD) within the last quarter, with a total of 3 bullish, 6 somewhat bullish, and 6 indifferent ratings. The average 12-month price target for Insulet is $254.87, a decrease of 19.38% from the previous average price target of $316.14.

Portfolio Pulse from Benzinga Insights

October 16, 2023 | 8:00 pm

AZO

AutoZone (NYSE:AZO) has outperformed the market over the past 20 years, producing an average annual return of 17.98%. If an investor had bought $100 of AZO stock 20 years ago, it would be worth $2,768.27 today. The company currently has a market capitalization of $46.58 billion.

Portfolio Pulse from Benzinga Insights

October 16, 2023 | 8:00 pm

AXP

American Express's (NYSE:AXP) short percent of float has fallen 4.31% since its last report, with 6.47 million shares sold short, which is 1.11% of all regular shares available for trading. This decrease in short interest could signal a more bullish market sentiment towards the stock. Compared to its peers, American Express has less short interest, with an average of 7.62% for its peer group.

Portfolio Pulse from Benzinga Insights

October 16, 2023 | 8:00 pm

CMPS

CYBN

GHRS

MNMD

PSIL

Cybin Inc. (NYSE:CYBN) and Small Pharma Inc. (OTC:DMTTF) shareholders have approved the acquisition of the latter by the former. The FDA has issued a warning about the misuse of ketamine and ketamine-based drugs. The DEA has extended telemedicine flexibilities for controlled medications until the end of 2024. California Governor Gavin Newsom has vetoed a bill to decriminalize certain hallucinogens. Congress is discussing kratom product regulation. The AdvisorShares Psychedelics ETF (NYSE:PSIL) continues to show a downtrend in its opening price. Several psychedelic stocks, including GH Research (NASDAQ:GHRS), COMPASS Pathways (NASDAQ:CMPS), and Mind Medicine (NASDAQ:MNMD), also closed lower.

Portfolio Pulse from Lara Goldstein

October 16, 2023 | 7:57 pm

ALL

Allstate's stock price is increasing after a report indicated that Trian Fund Management has acquired a stake in the company.

Portfolio Pulse from Benzinga Newsdesk

October 16, 2023 | 7:54 pm

PFE

Pfizer's stock has been upgraded from Hold to Buy by Jefferies, leading to a rise in the company's shares.

Portfolio Pulse from Benzinga Newsdesk

October 16, 2023 | 7:52 pm

CNSL

Consolidated Communications Holdings, Inc. (NASDAQ:CNSL) has announced an agreement to be acquired by Searchlight Capital Partners and British Columbia Investment Management in an all-cash transaction valued at approximately $3.1 billion. The deal will result in Consolidated Communications becoming a private company and its shares will no longer be traded or listed on any public securities exchange. The transaction is expected to close by Q1 2025.

Portfolio Pulse from Ryan Gustafson

October 16, 2023 | 7:48 pm

MARA

Shares of Marathon Digital Holdings Inc (NASDAQ:MARA) rose by 6.7% following a spike in Bitcoin due to a now-refuted rumor of Bitcoin spot ETF approval. The company, which primarily engages in Bitcoin mining, could see increased profitability from mining operations when the Bitcoin price is higher. The rumor about a Bitcoin spot ETF approval could have triggered speculative trading in Marathon Digital's stock.

Portfolio Pulse from Henry Khederian

October 16, 2023 | 7:46 pm

IQV

IQVIA Hldgs Inc.'s shares are currently trading at $198.31, marking a 0.53% decrease. Despite a 4.66% decrease over the past month, the stock has risen by 8.04% over the past year. The company's P/E ratio is 34.25, lower than the industry average of 64.34, which could indicate that the stock is undervalued or that shareholders do not expect future growth.

Portfolio Pulse from Benzinga Insights

October 16, 2023 | 7:45 pm

VSTS

JP Morgan has initiated coverage on Vestis with an Overweight rating and a price target of $20, leading to a rise in Vestis' stock price.

Portfolio Pulse from Benzinga Newsdesk

October 16, 2023 | 7:42 pm